The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

Thermo Fisher Scientific: Biologics overview

Fact Sheet

Biologics, or therapeutics derived from living organisms, are classified as large molecule drugs. Despite their inherent complexity in development and manufacturing, biologics are increasingly used to treat and prevent flare-ups of diseases like cancers, Crohn's disease, multiple sclerosis, and cystic fibrosis. Their incredible ability to manage and reduce systemic and gastrointestinal inflammation makes them a transformational asset in modern medicine.

Thermo Fisher Scientific has industry-leading expertise in the biologics space, having contributed to over 240 biologics programs. The challenges, risks, and costs of bringing complex large molecules to market are substantial, making competitive advantage challenging to achieve. With 20 years of experience, Thermo Fisher Scientific provides flexible, end-to-end solutions and expertise in development and manufacturing, supported by advanced technical capabilities.

Download our fact sheet for an overview of Thermo Fisher Scientific’s CDMO services and solutions specifically for biologics.

Thermo Fisher Scientific: Biologics overview